VanEck Associates’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

VanEck Associates’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,062	Closed	-$55K	–	861
2019 Q1	$55K	Buy	1,062 +1	+0.1%	+$48	﹤0.01%	786
2018 Q4	$42K	Buy	1,061 +20	+2%	+$929	﹤0.01%	764
2018 Q3	$54K	Sell	1,041 -63	-6%	-$3.08K	﹤0.01%	758
2018 Q2	$52K	Hold	1,104	–	–	﹤0.01%	798
2018 Q1	$39K	Buy	1,104 +35	+3%	+$1.37K	﹤0.01%	710
2017 Q4	$47K	Sell	1,069 -15	-1%	-$701	﹤0.01%	703
2017 Q3	$57K	Buy	+1,084	New	+$60.4K	﹤0.01%	712
2017 Q1	–	Sell	-646	Closed	-$34K	–	910
2016 Q4	$34K	Buy	646 +319	+98%	+$15.4K	﹤0.01%	801
2016 Q3	$15K	Sell	327 -86	-21%	-$3.73K	﹤0.01%	851
2016 Q2	$16K	Buy	413 +40	+11%	+$1.76K	﹤0.01%	832
2016 Q1	$15K	Buy	+373	New	+$15.4K	﹤0.01%	810

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VanEck Associates's SYNH Position: Q2 2019 in Review

VanEck Associates sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2019, closing a stake of 1,062 shares — an estimated $55K sold.

VanEck Associates first reported a position in SYNH in Q1 2016 and held it in 11 quarters. The position peaked at $57K in Q3 2017. 246 funds tracked by Wall St. Rank hold SYNH as of Q2 2019.

VanEck Associates reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2019 after selling out during the quarter.
VanEck Associates sold 1,062 Syneos Health, Inc. Class A Common Stock shares in Q2 2019, an estimated $55K.
VanEck Associates first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 11 quarters.
VanEck Associates's Syneos Health, Inc. Class A Common Stock position peaked at $57K in Q3 2017.
246 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2019.

Based on VanEck Associates's 13F filing for Q2 2019, filed 7 Aug 2019.